|
LOC643837 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.889000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.093600E-01 |
| Normal-vs-Stage2 |
1.096190E-01 |
| Normal-vs-Stage3 |
1.642370E-01 |
| Normal-vs-Stage4 |
9.397000E-03 |
| Stage1-vs-Stage2 |
1.418160E-02 |
| Stage1-vs-Stage3 |
1.073560E-02 |
| Stage1-vs-Stage4 |
3.557100E-04 |
| Stage2-vs-Stage3 |
6.387600E-01 |
| Stage2-vs-Stage4 |
6.037600E-01 |
| Stage3-vs-Stage4 |
2.505800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.333000E-01 |
| Normal-vs-AfricanAmerican |
9.095800E-01 |
| Normal-vs-Asian |
2.145600E-01 |
| Caucasian-vs-AfricanAmerican |
4.796000E-01 |
| Caucasian-vs-Asian |
3.172400E-02 |
| AfricanAmerican-vs-Asian |
1.003590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.728830E-01 |
| Normal-vs-Female |
5.350800E-01 |
| Male-vs-Female |
4.176200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.121200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.074200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.915600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.562000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.039600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.897000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.691200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.393800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.852600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.515600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.274100E-02 |
| Normal-vs-Grade 2 |
2.737400E-01 |
| Normal-vs-Grade 3 |
1.002160E-01 |
| Normal-vs-Grade 4 |
6.196500E-03 |
| Grade 1-vs-Grade 2 |
1.310200E-02 |
| Grade 1-vs-Grade 3 |
9.580900E-04 |
| Grade 1-vs-Grade 4 |
4.800000E-03 |
| Grade 2-vs-Grade 3 |
4.716600E-03 |
| Grade 2-vs-Grade 4 |
5.383100E-04 |
| Grade 3-vs-Grade 4 |
1.673000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.534200E-02 |
| Normal-vs-ccB subtype |
2.473600E-02 |
| ccA subtype-vs-ccB subtype |
1.95401999999456E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.581500E-02 |
| Normal-vs-N1 |
2.430600E-01 |
| N0-vs-N1 |
6.054400E-01 |
|
|
